AAAAAA
Results: 26-31/31
Authors:
DeNardo, GL
DeNardo, SJ
Shen, S
DeNardo, DA
Mirick, GR
Macey, DJ
Lamborn, KR
Citation: Gl. Denardo et al., Factors affecting I-131-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia, J NUCL MED, 40(8), 1999, pp. 1317-1326
Authors:
DeNardo, SJ
DeNardo, GL
Kukis, DL
Shen, S
Kroger, LA
DeNardo, DA
Goldstein, DS
Mirick, GR
Salako, Q
Mausner, LF
Srivastava, SC
Meares, CE
Citation: Sj. Denardo et al., Cu-67-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma, J NUCL MED, 40(2), 1999, pp. 302-310
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Carr, CE
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma, J NUCL MED, 40(12), 1999, pp. 2014-2020
Authors:
Shen, S
DeNardo, GL
Sgouros, G
O'Donnell, RT
DeNardo, SJ
Citation: S. Shen et al., Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body, J NUCL MED, 40(12), 1999, pp. 2102-2106
Authors:
O'Donnell, RT
DeNardo, SJ
Miers, LA
Kukis, DL
Mirick, GR
Kroger, LA
DeNardo, GL
Citation: Rt. O'Donnell et al., Combined modality radioimmunotherapy with taxol and Y-90-LYM-1 for Raji lymphoma xenografts, CANC BIO R, 13(5), 1998, pp. 351-361
Authors:
Kukis, DL
DeNardo, SJ
DeNardo, GL
O'Donnell, RT
Meares, CF
Citation: Dl. Kukis et al., Optimized conditions for chelation of Yttrium-90-DOTA immunoconjugates, J NUCL MED, 39(12), 1998, pp. 2105-2110